Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression

Thumbnail
View/ Open

Show full item record

Author
McCubrey, James A.
URI
http://hdl.handle.net/10342/9628
Subject
 drug transporters; MEK1; cancer stem cells 
Date
2017-12-06
Citation:
APA:
McCubrey, James A.. (December 2017). Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression. Oncotarget, (8:68), p.113013-113033. Retrieved from http://hdl.handle.net/10342/9628

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A.. "Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression". Oncotarget. 8:68. (113013-113033.), December 2017. May 24, 2022. http://hdl.handle.net/10342/9628.
Chicago:
McCubrey, James A., "Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression," Oncotarget 8, no. 68 (December 2017), http://hdl.handle.net/10342/9628 (accessed May 24, 2022).
AMA:
McCubrey, James A.. Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression. Oncotarget. December 2017; 8(68) 113013-113033. http://hdl.handle.net/10342/9628. Accessed May 24, 2022.
Collections